CHRO
USDChromocell Therapeutics Corporation Common Stock
$1.350-0.050 (-3.571%)
即時價格
Healthcare
生物科技
美國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$1.400
最高
$1.410
最低
$1.230
交易量
0.03M
公司基本面
市值
8.9M
行業
生物科技
國家
United States
交易統計
平均交易量
0.08M
交易所
ASE
貨幣
USD
52週範圍
最低 $1.2301當前 $1.350最高 $38
相關新聞
GlobeNewswire
Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement
The combined company plans to launch ZELSUVMI™ for the treatment of molluscum contagiosum infections in July 2025 Concurrent with the closing of the merger, the combined company closed on a $50.1 million equity
查看更多
GlobeNewswire
Channel Therapeutics Announces Reverse Common Stock Split in Conjunction with the Close of the Merger with Pelthos Therapeutics and Concurrent $50.1 Million Private Placement
FREEHOLD, N.J., June 27, 2025 (GLOBE NEWSWIRE) -- Channel Therapeutics Corporation, ("Channel" or the "Company"), (NYSE:CHRO), an emerging leader in the development of non-opioid pain treatment therapeutics, today
查看更多
